PBM Latest Press Releases

-- October 21, 2026 --

Psyence BioMed Completes PsyLabs Investment as Ibogaine Milestones Are Met Globe Newswire 7:00 AM

-- October 5, 2026 --

Psyence BioMed Partners with DEA-Registered Benuvia Operations to Establish U.S. Manufacture of Pharmaceutical-Grade Ibogaine Globe Newswire 7:00 AM

-- September 28, 2026 --

Psyence BioMed Announces Exclusive U.S. Ibogaine Licence for Texas Ibogaine Research Corporation Globe Newswire 7:00 AM

-- September 23, 2026 --

Psyence BioMed Announces Strategic Ibogaine Investment Globe Newswire 7:00 AM

-- September 14, 2026 --

Psyence BioMed Establishes Texas Ibogaine Research Corporation to Advance U.S. Ibogaine Development Globe Newswire 7:00 AM

-- August 18, 2026 --

Psyence BioMed Welcomes U.S. Administration's Latest Action to Accelerate Ibogaine Development Globe Newswire 5:23 PM

Market Data Delayed 15 Minutes